Thymidylate synthase (ThS) is a target for antimetabolite antitumor drugs. Such drugs have been
and quinazolin-4-imine derivatives, well-known
antifolate thymidylate synthase (TYMS)
inhibitors, has been
Ligacheva, A.A.,
Sherstoboev, E.Y.,
Danilets, M.G.,
Trofimova, E.S.,
Krivoshchekov, S.V.,
Khasanova, S.R.,
Kudashkina, N.V.,
Gur’ev, A.M.,
Belousov, M.V. (2021) -presenting cells by increasing NO
synthase activity and reducing arginase expression. © 2021, Springer Science
on the activity of hydrolytic enzymes (amylases and proteinases) and their protein
inhibitors in the leaves
Дьяконов, В.А.,
Джемилева, Л.У.,
Джемилев, У.М.,
D'yakonov, V.A.,
Dzhemileva, L.U.,
Dzhemilev, U.M. (2017) of researchers carry out an intensive search and selection of natural topoisomerase
inhibitors, as well as work
YARULLINA, L.G.,
KASIMOVA, R.I.,
AKHATOVA, A.R.,
MAKSIMOV, I.V.,
IBRAGIMOV, R.I.,
TSVETKOV, V.O.,
YARULLINA, L.M. (2016) of acetylation (DA) on gene expression of protective proteins (oxalate oxidase, peroxidase, proteinase
inhibitors therapies for aggressive cancer and leukemia. An NF-kappa B
inhibitor named dehydroxymethylepoxyquinomicin